World's First Test for Early-Stage Pancreatic Cancer,"N-NOSE® plus Pancreas", Now Available
N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes. The test has been available to the public in Japan in January 2020.
What is N-NOSE?
Merit of taking a cancer screening test
Why nematodes?
The world's first biological ”diagnostic” technology. At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.
Message from CEO
Company Profile
Company History
List of Officers
The world’s first cancer screening using biological diagnostic technology